Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China · Delayed Price · Currency is CNY 4.880
+0.030 (0.62%)
Mar 26, 2026, 3:04 PM CST
SHE:300006 Revenue
In the year 2025, Chongqing Lummy Pharmaceutical had annual revenue of 775.69M CNY, down -2.50%. Chongqing Lummy Pharmaceutical had revenue of 194.62M in the quarter ending December 31, 2025, with 2.46% growth.
Revenue
775.69M
Revenue Growth
-2.50%
P/S Ratio
6.60
Revenue / Employee
761.22K
Employees
1,019
Market Cap
5.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 775.69M | -19.91M | -2.50% |
| Dec 31, 2024 | 795.60M | -99.99M | -11.17% |
| Dec 31, 2023 | 895.59M | 11.01M | 1.24% |
| Jan 1, 2023 | 884.59M | -340.64M | -27.80% |
| Dec 31, 2021 | 1.23B | -358.31M | -22.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Zhejiang Zhenyuan Share | 2.67B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Shanghai InnoStar Bio-tech | 811.33M |
| Hangzhou Minsheng Healthcare | 744.06M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |